Join
Live feed
·
INSIDERFilingvia Quantisnow
KalVista Pharmaceuticals Inc. logo

Large owner Venrock Healthcare Capital Partners Iii, L.P. bought $621,628 worth of shares (70,023 units at $8.88) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KALV· KalVista Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALV (KalVista Pharmaceuticals Inc.) and more on Quantisnow.